U.S. panel narrowly backs Mela skin cancer device | Reuters
(Reuters) - U.S. medical advisers narrowly backed Mela Sciences Inc's experimental skin cancer detection device on Thursday, with some advocating the new technology while others said the company's data was questionable.
No comments:
Post a Comment